CCT369260

E3 Ligase: CCT369260 recruits the cereblon (CRBN) E3 ligase, facilitating selective ubiquitination of neosubstrate proteins. This recruitment stabilizes the ternary complex necessary for proteasomal degradation.

Target Protein: CCT369260 primarily targets IKZF1 and IKZF3 transcription factors, which are involved in lymphoid cell development and transcriptional regulation. Engagement promotes their recognition by CRBN.

Degradation Mechanism: CCT369260 mediates proteasomal degradation via the ubiquitin–proteasome system. The CRBN–IKZF1/3 ternary complex drives polyubiquitination and subsequent clearance by the 26S proteasome.

• Molecular Glue Mechanism Exploration: CCT369260 serves as a valuable tool in investigating the molecular glue mechanism, facilitating the study of how small molecules induce protein-protein interactions that lead to targeted protein degradation. Researchers can utilize this compound to dissect the intricate processes involved in selective protein modulation.

• Targeted Degradation Pathway Analysis: Employ CCT369260 to elucidate pathways involved in targeted protein degradation. This compound aids in understanding the degradation of specific proteins by harnessing the molecular glue mechanism, offering insights into cellular regulation and protein homeostasis.

• Protein-Protein Interaction Studies: With CCT369260, researchers can delve into the dynamics of protein-protein interactions mediated by molecular glues. This application is crucial for identifying potential therapeutic targets and understanding the structural basis of induced protein interactions.

• Drug Discovery and Development: CCT369260 is instrumental in drug discovery efforts focused on molecular glue compounds. By enabling the study of targeted degradation pathways, it aids in the identification and optimization of novel therapeutic agents aimed at modulating disease-relevant proteins.